H.R. 7391

119th CongressIn committee

Community Health Center Drug Pricing Protection Act

Community Health Center Drug Pricing Protection Act

Sponsored by Jack Bergman (Republican-MI-1)

Healthcare Costs & Access Healthcare & Public Health Pharmaceutical Policy

Cosponsors

54

Actions

3

Roll calls

0

Amendments

0

Related bills

0

Actions

Feb 5, 2026 · Library of Congress

Introduced in House

Feb 5, 2026 · Library of Congress

Introduced in House

Feb 5, 2026 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

Activity

July 2026

Lobbying reported · Bristol Myers Squibb · Jul 20

Bristol Myers Squibb reported 2nd Quarter (Apr 1 - June 30) lobbying for Bristol Myers Squibb — $3,160,000

BillsH.R. 1492 H.R. 4299 H.R. 5509 H.R. 7391 H.R. 7635

Lobbying reported · National Association of Community Health Centers · Jul 20

National Association of Community Health Centers reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association of Community Health Centers — $213,000

BillsH.R. 935 H.R. 3164 H.R. 4206 H.R. 5081 H.R. 5496 H.R. 7391 H.R. 8201 H.R. 9389 S. 1261 S. 2709 S. 4254

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Johnson & Johnson Services · Jul 20

Johnson & Johnson Services reported 2nd Quarter (Apr 1 - June 30) lobbying for Johnson & Johnson Services — $1,440,000

Lobbying reported · Pfizer · Jul 20

Pfizer reported 2nd Quarter (Apr 1 - June 30) lobbying for Pfizer — $1,880,000

BillsH.Con.Res. 14 H.R. 1 H.R. 4299 H.R. 4930 H.R. 5178 H.R. 5526 H.R. 7391 H.R. 7837 H.R. 8646 H.R. 9102 H.R. 9260 S. 2658

Lobbying reported · 340b Health · Jul 20

340b Health reported 2nd Quarter (Apr 1 - June 30) lobbying for 340b Health — $240,000

BillsH.R. 4581 H.R. 7391 H.R. 9504 H.R. 9599

Lobbying reported · Advanced Policy Consulting · Jul 17

Advanced Policy Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $40,000

BillsH.R. 1492 H.R. 7391 S. 832

Lobbying reported · Glaxosmithkline · Jul 16

Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000

You’re all caught up.